How to buy Cytosorbents Crp stock (CTSO)

Cytosorbents Crp is a medical devices business based in the US. Cytosorbents Crp shares (CTSO) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $0.94 – an increase of 2.72% over the previous week. Cytosorbents Crp employs 186 staff and has a trailing 12-month revenue of around $37.7 million.

Our top picks for where to buy Cytosorbents Crp stock

Buy Cytosorbents Crp stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Cytosorbents Crp stock price (NASDAQ: CTSO)

Use our graph to track the performance of CTSO stocks over time.

Cytosorbents Crp shares at a glance

• Key figures

Information last updated 2024-12-25.

Latest market close	$0.94
52-week range	$0.70 - $1.59
50-day moving average more info button	$0.95
200-day moving average more info button	$0.98
Wall St. target price	$5.00
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-0.36

Is it a good time to buy Cytosorbents Crp stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Cytosorbents Crp price performance over time

Historical closes compared with the close of $0.9 from 2024-12-26

1 week (2024-12-20)	-1.64%
1 month (2024-11-27)	-1.12%
3 months (2024-09-27)	-40.00%
6 months (2024-06-27)	16.50%

1 year (2023-12-27)	-44.79%
2 years (2022-12-27)	-38.36%
3 years (2021-12-27)	4.38
5 years (2019-12-27)	3.83

Cytosorbents Crp financials

Revenue TTM	$37.7 million
Gross profit TTM	$20.7 million
Return on assets TTM	-27.93%
Return on equity TTM	-118.5%
Profit margin	-49.47%
Book value	$0.24
Market Capitalization more info button	$49.1 million

TTM: trailing 12 months

Cytosorbents Crp share dividends

We're not expecting Cytosorbents Crp to pay a dividend over the next 12 months.

Have Cytosorbents Crp's shares ever split?

Cytosorbents Crp's shares were split on a 1:25 basis on 4 December 2014 . So if you had owned 25 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Cytosorbents Crp shares – just the quantity. However, indirectly, the new 2400% higher share price could have impacted the market appetite for Cytosorbents Crp shares which in turn could have impacted Cytosorbents Crp's share price.

Cytosorbents Crp share price volatility

Over the last 12 months, Cytosorbents Crp's shares have ranged in value from as little as $0.7 up to $1.59. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Cytosorbents Crp's is 0.564. This would suggest that Cytosorbents Crp's shares are less volatile than average (for this exchange).

Cytosorbents Crp overview

Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology in the United States, Germany, and internationally. Its flagship product is CytoSorb, an extracorporeal cytokine adsorber for adjunctive therapy in the treatment of sepsis, adjunctive therapy in other critical care applications, prevention, and treatment of perioperative complications, and maintaining or enhancing the quality of solid organs harvested from donors for organ transplant; and offers VetResQ, a device for adjunctive therapy in the treatment of sepsis, pancreatitis, and other critical illnesses in animals. The company also develops CytoSorb-XL, a device for adjunctive therapy in the treatment of sepsis and other critical illnesses; HemoDefend blood purification technology platform to reduce contaminants in the blood supply that can cause transfusion reactions or disease when administering blood and blood products to patients, and removal of anti-A and anti-B blood group antibodies from whole blood and plasma; K+ontrol for treatment of severe hyperkalemia in patients with life-threatening conditions; and ContrastSorb for the removal of IV contrast in blood administered during CT imaging, an angiogram, or during a vascular interventional radiology procedure to reduce the risk of contrast-induced nephropathy. In addition, it develops BetaSorb, a device for the prevention and treatment of health complications caused by the accumulation of metabolic toxins in patients with chronic renal failure; DrugSorb, a device to remove drugs and chemicals from the blood; and DrugSorb-ATR, an antithrombotic removal system. The company was formerly known as MedaSorb Technologies Corporation and changed its name to Cytosorbents Corporation in May 2010. Cytosorbents Corporation was founded in 1997 and is headquartered in Princeton, New Jersey. .

Frequently asked questions

null
What percentage of Cytosorbents Crp is owned by insiders or institutions?
Currently 3.902% of Cytosorbents Crp shares are held by insiders and 33.287% by institutions. How many people work for Cytosorbents Crp?
Latest data suggests 186 work at Cytosorbents Crp. When does the fiscal year end for Cytosorbents Crp?
Cytosorbents Crp's fiscal year ends in December. Where is Cytosorbents Crp based?
Cytosorbents Crp's address is: 305 College Road East, Princeton, NJ, United States, 08540 What is Cytosorbents Crp's ISIN number?
Cytosorbents Crp's international securities identification number is: US23283X2062 What is Cytosorbents Crp's CUSIP number?
Cytosorbents Crp's Committee on Uniform Securities Identification Procedures number is: 58404X107